Search results for: R korman
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 3

Search results for: R korman

3 Treatment of Feline Infectious Peritonitis in Cats with Molnupiravir: Clinical Observations and Outcomes For 54 Cases

Authors: T. M. Clark, S. J. Coggins, R. Malik, J. King, R. Korman

Abstract:

Objectives: This observational study investigated the use of molnupiravir for treatment of cats with naturally occurring feline infectious peritonitis. Methods: From September 2022 to February 2024, 66 cats diagnosed with FIP across 32 veterinary practices, mainly in Australia, were enrolled. Of these, 54 cats met the inclusion criteria. Complete remission was defined by the resolution of clinical signs and normalisation of A:G ratio (to ≥0.6). Presumptive remission was defined as sustained resolution of FIP-related clinical signs for at least 100 days post cessation of antiviral therapy. Results: In Cohort 1, 18 cats were treated with molnupiravir monotherapy. Thirteen achieved complete remission and three attained presumptive remission, resulting in an overall remission rate of 89% and a provisional cure rate of 72%, with three relapses. Cohort 2 included 29 cats treated with a short induction course of GS-441524 and/or remdesivir before switching to molnupiravir; 23 attained complete remission, and two achieved presumptive remission. The overall cure rate was 86% with no relapses. Seven cats in cohort 3 were initially treated with extended courses of GS-441524, remdesivir, and/or mefloquine and experienced treatment failure or relapse. Molnupiravir was introduced as a rescue therapy; 6 achieved complete remission and 1 achieved presumed remission, resulting in a 100% cure rate with no relapses. Few adverse effects were reported, with the most notable including neutropenia, transient elevations in hepatic enzymes, and polydipsia/polyuria. Conclusion and Relevance: Molnupiravir as a monotherapy, or in combination with other antivirals, represents an accessible, effective treatment for FIP when given at a dosage of 10-15 mg/kg BID. Success occurred across various presentations of FIP, including cases with ocular and neurological involvement.

Keywords: feline infectious peritonitis, FIP, molnupiravir, nucleoside analogue, antiviral

Procedia PDF Downloads 22
2 Treatment of feline infectious peritonitis in cats with molnupiravir: Outcomes for 54 cases

Authors: TM Clark, SJ Coggins, R korman, J King, R Malik

Abstract:

Objective To evaluate the clinical applications and treatment outcomes using molnupiravir (MPV) for the treatment of naturally occurring feline infectious peritonitis. Methods , 92 client-owned cats with confirmed or presumptive FIP were retrospectively recruited from 35 veterinary practices between February 2023 and March 2024, primarily in Australia. Cats were categorised based on treatment received: Cohort A: Molnupiravir treatment: monotherapy, maintenance, and rescue therapy. Cohort B: Nucleoside analogue treatment: remdesivir and/or GS-441524. Seventy-eight cats were enrolled. Molnupiravir was administered orally for a median of 84 days, at a median dose of 13.3 mg/kg BID. Remission was defined as (i) the resolution of FIP-related clinical signs and normalisation of serum globulin concentrations and A:G ratio (to ≥0.6) or (ii) sustained clinical remission for at least 100 days post-treatment. Cure rate was defined as the percentage of cats achieving sustained remission, without requiring rescue therapy or experiencing a relapse event. Results Molnuparivir monotherapy resulted in a cure rate of 72% (13/18) while maintenance therapy resulted in a cure rate of 86% (25/29). Molnupiravir, utilised as rescue therapy, resulted in a cure rate of 100% (7/7). Treatment with remdesivir and/or GS-441524 resulted in a cure rate of 71% (17/24). Survival analysis revealed no significant difference in outcomes between cats treated with MPV monotherapy and those treated with nucleoside analogues. Adverse effects were uncommon but included neutropenia, and transient elevations in hepatic enzymes. Conclusion and Relevance In our study, molnupiravir demonstrated comparable outcomes to treatment with remdesivir and/or GS-441524 for treating FIP and serves as an accessible, effective option across various presentations, including ocular and neurological forms.

Keywords: FIP, molnupiravir, antiviral, nucleoside analogue

Procedia PDF Downloads 2
1 Effects of Evening vs. Morning Training on Motor Skill Consolidation in Morning-Oriented Elderly

Authors: Maria Korman, Carmit Gal, Ella Gabitov, Avi Karni

Abstract:

The main question addressed in this study was whether the time-of-day wherein training is afforded is a significant factor for motor skill ('how-to', procedural knowledge) acquisition and consolidation into long term memory in the healthy elderly population. Twenty-nine older adults (60-75 years) practiced an explicitly instructed 5-element key-press sequence by repeatedly generating the sequence ‘as fast and accurately as possible’. Contribution of three parameters to acquisition, 24h post-training consolidation, and 1-week retention gains in motor sequence speed was assessed: (a) time of training (morning vs. evening group) (b) sleep quality (actigraphy) and (c) chronotype. All study participants were moderately morning type, according to the Morningness-Eveningness Questionnaire score. All participants had sleep patterns typical of age, with average sleep efficiency of ~ 82%, and approximately 6 hours of sleep. Speed of motor sequence performance in both groups improved to a similar extent during training session. Nevertheless, evening group expressed small but significant overnight consolidation phase gains, while morning group showed only maintenance of performance level attained at the end of training. By 1-week retention test, both groups showed similar performance levels with no significant gains or losses with respect to 24h test. Changes in the tapping patterns at 24h and 1-week post-training were assessed based on normalized Pearson correlation coefficients using the Fisher’s z-transformation in reference to the tapping pattern attained at the end of the training. Significant differences between the groups were found: the evening group showed larger changes in tapping patterns across the consolidation and retention windows. Our results show that morning-oriented older adults effectively acquired, consolidated, and maintained a new sequence of finger movements, following both morning and evening practice sessions. However, time-of-training affected the time-course of skill evolution in terms of performance speed, as well as the re-organization of tapping patterns during the consolidation period. These results are in line with the notion that motor training preceding a sleep interval may be beneficial for the long-term memory in the elderly. Evening training should be considered an appropriate time window for motor skill learning in older adults, even in individuals with morning chronotype.

Keywords: time-of-day, elderly, motor learning, memory consolidation, chronotype

Procedia PDF Downloads 136